Today: 3 July 2026
Telstra stock price ends flat as investors brace for half-year results, dividend call
17 February 2026
1 min read

Telstra stock price ends flat as investors brace for half-year results, dividend call

Sydney, Feb 17, 2026, 17:44 AEDT — Market closed.

  • Telstra closed flat at A$4.95, trailing a small uptick in the wider market.
  • Half-year results drop for the telco on Feb. 19, and interim dividend dates aren’t far off.
  • Central bank minutes flagged uncertainty around the next move, keeping rate expectations in the spotlight.

Telstra Group Limited closed unchanged on Tuesday at A$4.95. Shares moved between A$4.94 and A$5.00 throughout the session. Roughly 13.6 million shares changed hands, almost matching Monday’s volume.

The stock edges into a packed stretch for income-focused investors. Telstra’s half-year results land on Thursday, with the interim dividend calendar already locked in: ex-dividend date arrives Feb. 25, record follows on Feb. 26, and payout hits on March 27. (Anyone buying from the ex-dividend date onward misses out on the dividend.)

Telstra plans to webcast its FY26 half-year results presentation on Feb. 19.

Tuesday wrapped with the S&P/ASX 200 climbing 0.24%, miners and materials putting points on the board, market data showed. Telstra, meanwhile, was flat and didn’t keep pace with the sector.

Rates have figured into the mix as well. The Reserve Bank of Australia minutes from February revealed the board lacked conviction on “any particular path” for the cash rate after raising it to 3.85%. Markets, for now, continue to price in the chance of a further increase in May. Reuters

Telstra investors on Thursday will be eyeing more than just headline figures. The key focus: where mobile and broadband pricing shakes out, if cost cuts are still carrying their weight, and any fresh hints from management on the outlook for the second half.

There’s the dividend side, too. According to Telstra’s investor materials, the company generally hands out an interim dividend in March and a final one in September, pending board sign-off. Eligible shareholders can opt into a dividend reinvestment plan.

The market’s betting on things staying steady here. But if margins miss, operating trends cool off, or the dividend falls short for yield hunters, this stock—long seen as a defensive play in turbulent rate conditions—could take a hit.

According to Investing.com, analysts are calling for an average 12-month target of about A$4.97. That’s basically where the stock closed on Tuesday.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • AbbVie Jumps 4%, Tops Apogee Buy Price After Earnings Beat
    July 2, 2026, 7:16 PM EDT. AbbVie Inc. finished up 3.99% at $261.07, a new 52-week high. The stock gained nearly $17.8 billion in market cap, putting it well above the $10.9 billion Apogee Therapeutics deal announced June 22. AbbVie closed above targets from RBC Capital, Investing.com and Google Finance. With Q2 earnings set for July 31, the rally puts the spotlight on analyst target hikes. J.P. Morgan and RBC Capital have backed the Apogee buy for its long-term growth, with the company saying the acquisition will add to EPS by 2032. AbbVie outpaced broader markets, which slipped slightly, as investors bet on the drugmaker's deal strategy.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop